IBEX Earnings

IBEX reported its earnings on 2026-02-05, showcasing a revenue of 164.22M against an estimate of 157.00M, resulting in a 4.6% surprise. The EPS was 0.79, surpassing the expected 0.79 by 0%. The stock experienced a 2.25% price change on the earnings day and a -11.81% change over the next five days, reflecting market reactions to the results.

Following IBEX's earnings announcement on 2026-02-05, the stock price moved by 2.25% on the day of the release. Over the subsequent five days, it saw a -11.81% change. Historically, IBEX's stock price tends to shift by an average of 1.04% in the 10 days leading up to earnings and 5.18% in the 10 days following, providing insight into potential market.

For 2026/Q3, analysts estimate IBEX's annual revenue to reach 153.75M, while the EPS is projected at 0.91. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between IBEX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, IBEX's stock price typically moves by 1.04% in the 10 days before its earnings and 5.18% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of 0.91 and revenue of 153.75M.

The earnings report indicates strong financial performance with a 16.7% revenue increase, improved EBITDA, and EPS growth. Despite challenges in the telecommunications vertical and increased capital expenditures, the company shows promising growth in high-margin sectors like HealthTech and AI. The raised revenue and EBITDA guidance further support a positive sentiment. The share repurchase program adds to shareholder value. The Q&A session confirmed favorable business mix shifts and long-term margin improvement strategies. Overall, the outlook is positive, suggesting a stock price increase of 2% to 8% over the next two weeks.